NCT02144896

Brief Summary

Endothelial function of the skeletal muscle vasculature declines with advancing age. Although aerobic exercise training is commonly prescribed to combat loss of endothelial function in the elderly, the rate of compliance to training programs is low. Contrary to aerobic exercise training, stretching exercise is widely performed in elderly patients to increase muscle flexibility and to prevent muscle atrophy induced by immobilization. However, it remains unknown as to whether regular stretching of the calf muscles using ankle dorsiflexion splinting improves muscle blood flow. The purpose of the proposed work is to test the hypothesis that performance of ankle dorsiflexion splinting improves endothelial function and lower leg muscle blood flow in older adults. Ankle dorsiflexion splinting will be performed on the randomized leg for 30 minutes, 5 times per week for 4 weeks. Leg vascular measures will be performed on the splinted and non-splinted legs prior to and at the end of the 4-week intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2014

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

May 15, 2014

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 22, 2014

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 10, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 10, 2015

Completed
Last Updated

April 5, 2018

Status Verified

April 1, 2018

Enrollment Period

11 months

First QC Date

May 15, 2014

Last Update Submit

April 4, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in vascular endothelial function of leg conduit artery

    Endothelium-dependent and endothelium-independent dilation of popliteal artery using ultrasonography.

    At baseline and after 4 weeks of ankle splinting

Secondary Outcomes (2)

  • Change in vascular endothelial function of calf resistance vessels

    At baseline and after 4 weeks of ankle splinting

  • Change in calf blood flow in response to acute ankle splinting

    Before and after 30 min of ankle splinting

Study Arms (2)

Ankle splinting

EXPERIMENTAL

Older adults will have one leg randomly assigned to ankle splinting for 4 weeks. The non-splinted leg will serve as the control.

Other: Ankle splinting

No Ankle Splinting

NO INTERVENTION

The non splinted leg will serve as the control

Interventions

Ankle dorsiflexion splinting will be performed 30 minutes per day, 5 days per week for 4 weeks.

Ankle splinting

Eligibility Criteria

Age60 Years - 79 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men and women aged 60 to 79 years.
  • Women will all be postmenopausal and must not take hormone replacement therapy.
  • Sedentary, defined as no regular exercise training.

You may not qualify if:

  • No evidence of heart disease evidenced by abnormal resting ECG, angina or ECG evidence of acute myocardial ischemia during the exercise test, no history of any relevant acute cardiac event (myocardial infarction, episode of heart failure)
  • No history of deep vein thrombosis.
  • No history of Type I or II diabetes mellitus.
  • No history for renal or liver disease.
  • No history of seizures, or other relevant on-going or recurrent illness.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Florida

Gainesville, Florida, 32611, United States

Location

Study Officials

  • Demetra D Christou, Ph.D

    University of Florida

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 15, 2014

First Posted

May 22, 2014

Study Start

May 1, 2014

Primary Completion

April 10, 2015

Study Completion

April 10, 2015

Last Updated

April 5, 2018

Record last verified: 2018-04

Data Sharing

IPD Sharing
Will not share

Locations